Metastatic Bone Disease Market size Expand with Significant CAGR during 2026 Metastatic Bone Disease Market size Expand with Significant CAGR during 2026 BriefingWire.com, 5/05/2021 - Global Metastatic Bone Disease Market was valued US$ 12.48 Bn in 2017 and is expected to reach US$ 23.2 Bn by 2026, at a CAGR of 8.06 % during a forecast period Bone metastasis begins when cancer cells spread from their original site such as the lungs, breast, and prostate to bone. Signs and symptoms of bone metastasis include: Bone pain&Broken bones Urinary &Bowel incontinence High levels of calcium in the blood, which can cause nausea, vomiting, constipation and confusion The improved prevalence of cancer, investment on the drug discovery & development, increasing senior population, and growing healthcare expenditures are driving the growth of global metastatic bone disease market. Furthermore, improved alertness about personalized medicine for the treatment of cancer condition is a key opportunity of the metastatic bone disease market. However, the growing use of generic medicine, lack of healthcare services in low-income countries, and high treatment cost is the factor which limits the growth of the global metastatic bone disease market.